Replies to post #223503 on Biotech Values

[semi_infinite]

EYPT - Dexycu (for post cataract surgery inflammation) commercial launch a couple of days ago. ER and CC. Progress as guided.

http://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-pharmaceuticals-announces-us-commercial-launch-dexycutm

https://edge.media-server.com/m6/p/hz6yprie

Apparently has good visibility on Yutiq uptake via eyepoint-assist program that helps with J-codes and getting insurance coverage, or co-pay assistance.

https://yutiq.com/downloads/YUT00026_EyePoint_Assist_Hub_Enrollment_Form.pdf